Variant report
Variant | nsv10721 |
---|---|
Chromosome Location | chr5:97400285-97403045 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575470828 | chr5:97400337-97400338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144288320 | chr5:97400390-97400391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187638917 | chr5:97400415-97400416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148733276 | chr5:97400434-97400435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368090232 | chr5:97400499-97400500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79847073 | chr5:97400512-97400513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs257215 | chr5:97400521-97400522 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs535790069 | chr5:97400550-97400551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552943072 | chr5:97400562-97400563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35321848 | chr5:97400563-97400564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565466014 | chr5:97400567-97400568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs77849316 | chr5:97400572-97400573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs72767640 | chr5:97400627-97400628 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs544504449 | chr5:97400666-97400667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs17088004 | chr5:97400688-97400689 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs530338740 | chr5:97400732-97400733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs193044094 | chr5:97400825-97400826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560162087 | chr5:97400830-97400831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527771153 | chr5:97400878-97400879 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144658446 | chr5:97400940-97400941 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147875584 | chr5:97400966-97400967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571088347 | chr5:97400968-97400969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538798306 | chr5:97401015-97401016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550516797 | chr5:97401033-97401034 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143012409 | chr5:97401068-97401069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368015767 | chr5:97401074-97401075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569091076 | chr5:97401076-97401077 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140220488 | chr5:97401253-97401254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73775110 | chr5:97401262-97401263 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs151106471 | chr5:97401301-97401302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554544319 | chr5:97401357-97401358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572913787 | chr5:97401375-97401376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533853998 | chr5:97401418-97401419 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185645578 | chr5:97401442-97401443 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188870383 | chr5:97401443-97401444 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377247915 | chr5:97401563-97401564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200650111 | chr5:97401564-97401565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534767763 | chr5:97401713-97401714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575076080 | chr5:97401775-97401776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568024609 | chr5:97401811-97401812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34681598 | chr5:97401834-97401835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs58683537 | chr5:97401956-97401957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192363249 | chr5:97401982-97401983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35474494 | chr5:97402048-97402049 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs115282201 | chr5:97402051-97402052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552175587 | chr5:97402058-97402059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564206492 | chr5:97402102-97402103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs199783818 | chr5:97402135-97402136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115144015 | chr5:97402136-97402137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141054364 | chr5:97402139-97402140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21611746 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:97398600-97401800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr5:97399200-97401400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr5:97399400-97400400 | Enhancers | Brain Cingulate Gyrus | brain |
4 | chr5:97399800-97400600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr5:97400000-97400400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr5:97400000-97400400 | Enhancers | Brain Germinal Matrix | brain |
7 | chr5:97400000-97401400 | Enhancers | Brain Substantia Nigra | brain |
8 | chr5:97400200-97400400 | Enhancers | Brain Inferior Temporal Lobe | brain |
9 | chr5:97400200-97400800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr5:97400200-97401400 | Enhancers | NHDF-Ad | bronchial |
11 | chr5:97400200-97401600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr5:97400800-97401400 | Enhancers | Brain Hippocampus Middle | brain |
13 | chr5:97400800-97404000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr5:97401200-97401600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr5:97401200-97401600 | Enhancers | Osteobl | bone |
16 | chr5:97401400-97402800 | Weak transcription | NHDF-Ad | bronchial |
17 | chr5:97401600-97402600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr5:97402600-97403000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr5:97402800-97403200 | Enhancers | NHDF-Ad | bronchial |